Article · 31 Oct 2025
Review articlePublished 27 May 2021
Cognitive Assessment with Neurocognitive Screening Tools
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Neurocognitive Disorders (NCDs) are widespread diseases, especially in elderly. The future possibility of having more effective treatments has to deal with the lack of early disorder detection, which would enable patients to benefit the most from them. Individual medical history, blood and cerebrospinal fluid tests, and neuroimaging, among other tools, support the diagnostic process; neurocognitive screening tests also have an irreplaceable role to play in NCD assessment. Ease of execution and low cost make these instruments to be so appreciate in clinical practice. Mini Mental State Examination (MMSE), Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), Montreal Cognitive Assessment (MoCA), and Clock Drawing Test (CDT), used as first-level screening tools, will be at the centre of this mini review. In the present work we will highlight the contribution made by these tests in NCD assessment, emphasizing some interesting aspects recently emerged from the scientific literature.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Aging Science.
Article · 31 Oct 2025
The Hallmarks of Aging Revisited: New Insights from Cellular Stress Pathways
Article · 31 Oct 2025
Microbiome and Longevity: How Gut Ecology Shapes the Aging Process
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Aging Science
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Francesco Salis”
- BylineArticles whose byline prints “Antonella Mandas”

